AN ACT relating to pharmaceutical manufacturers.

HB 772 amends Kentucky's definition of "transaction" under pharmaceutical distribution law to explicitly include pharmaceutical manufacturers. This clarifies that when manufacturers transfer drugs to distributors or other entities, those exchanges count as "transactions" under existing regulations. The bill does not create new requirements but ensures manufacturers are explicitly covered in the current tracking and recordkeeping framework for drug distribution. It directly affects pharmaceutical manufacturers, distributors, and pharmacies by standardizing how drug transfers are categorized under Kentucky law.